Beckman Coulter Diagnostics

250 S Kraemer Boulevard, Brea, CA 92821
Uncategorized
Uncategorized
back to directoryBack to Directory

Related Posts:

BECKMAN COULTER DIAGNOSTICS: FDA Emergency Use Authorization awarded to the Beckman Coulter Access IL-6 test
BECKMAN COULTER DIAGNOSTICS: FDA Emergency Use Authorization awarded to the Beckman Coulter Access IL-6 test

October 9, 2020

The Access Interleukin-6 (IL-6) assay is designed to assist physicians in the identification of severe inflammatory response in COVID-19 patients

Read more →
BECKMAN COULTER DIAGNOSTICS: Beckman Coulter’s Automated Blood Banking Analyzer Receives 510(k) FDA Clearance
BECKMAN COULTER DIAGNOSTICS: Beckman Coulter’s Automated Blood Banking Analyzer Receives 510(k) FDA Clearance

July 26, 2020

Beckman Coulter today announced that it has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its PK7400 Automated Microplate System and the system's reagents have completed FDA approval.

Read more →

Trending

BAYER: U.S. FDA Approves Addition of Overall Survival and Other Secondary Endpoint Data to NUBEQA® (darolutamide) Prescribing Information
LOCATE BIO: CognitOss Granted FDA Breakthrough Device Designation
NORTHSTAR MEDICAL RADIOISOTOPES: Announces FDA Approval for Enhanced U.S. Mo-99 Radioisotope Production Capacity
KING & SPALDING: FDA and Life Sciences Team Adds Partner in Washington
FUNCTIONAL NEUROMODULATION: Announces Breakthrough Device Designation from the U.S. FDA for Deep Brain Stimulation for Alzheimer’s Disease
ULTROMICS: Receives Fda Clearance for a First-of-kind Solution in Echocardiography to Help Clinicians Diagnose Disease

The Weekly Newsletter

Sign-up for the Weekly Newsletter from FDA Reporter.